PT - JOURNAL ARTICLE AU - Bryant, Luke AU - Free, Robert C AU - Woolf, Katherine AU - Melbourne, Carl AU - Guyatt, Anna L AU - John, Catherine AU - Gupta, Amit AU - Gray, Laura J AU - Nellums, Laura AU - Martin, Christopher A AU - McManus, I Chris AU - Garwood, Claire AU - Modhawdia, Vishant AU - Carr, Sue AU - Wain, Louise V AU - Tobin, Martin D AU - Khunti, Kamlesh AU - Akubakar, Ibrahim AU - Pareek, Manish AU - , TI - Cohort Profile: The United Kingdom Research study into Ethnicity And COVID-19 outcomes in Healthcare workers (UK-REACH) AID - 10.1101/2022.01.19.22268871 DP - 2022 Jan 01 TA - medRxiv PG - 2022.01.19.22268871 4099 - http://medrxiv.org/content/early/2022/01/27/2022.01.19.22268871.short 4100 - http://medrxiv.org/content/early/2022/01/27/2022.01.19.22268871.full AB - Key Features of the UK-REACH Cohort (Profile in a nutshell)The UK-REACH Cohort was established to understand why ethnic minority healthcare workers (HCWs) are at risk of poorer outcomes from COVID-19 when compared to their white ethnic counterparts in the United Kingdom (UK). Through study design, it contains a uniquely high percentage of participants from ethnic minority backgrounds about whom a wide range of qualitative and quantitative data has been collected.A total of 17891 HCWs aged 16-89 years (mean age: 44) have been recruited from across the UK via all major healthcare regulators, individual National Health Service (NHS) hospital trusts and UK HCW membership bodies who advertised the study to their registrants/staff to encourage participation in the study.Data available include linked healthcare records for 25 years from the date of consent and consent to obtain genomic sequencing data collected via saliva. Online questionnaires include information on demographics, COVID-19 exposures at work and home, redeployment in the workforce due to COVID-19, mental health measures, workforce attrition, and opinions on COVID-19 vaccines, with baseline (n=15 119), 6 (n=5632) and 12-month follow-up data captured.Request data access and collaborations by following documentation found at https://www.uk-reach.org/main/data_sharing.Competing Interest StatementKK is Director of the University of Leicester Centre for Black Minority Ethnic Health, Trustee of the South Asian Health Foundation and Chair of the Ethnicity Subgroup of the UK Government Scientific Advisory Group for Emergencies (SAGE). SC is Deputy Medical Director of the General Medical Council, UK Honorary Professor, University of Leicester. MP reports grants from Sanofi, grants and personal fees from Gilead Sciences and personal fees from QIAGEN, outside the submitted work.Clinical TrialISRCTN11811602Funding StatementUK-REACH is supported by a grant from the MRC-UK Research and Innovation (MR/V027549/1) and the Department of Health and Social Care through the National Institute for Health Research (NIHR) rapid response panel to tackle COVID-19. Core funding was also provided by NIHR Biomedical Research Centres. CAM is an NIHR Academic Clinical Fellow (ACF-2018-11-004). KW is funded through an NIHR Career Development Fellowship (CDF-2017-10-008). LBN is supported by an Academy of Medical Sciences Springboard Award (SBF005\1047). ALG was funded by internal fellowships at the University of Leicester from the Wellcome Trust Institutional Strategic Support Fund (204801/Z/16/Z) and the BHF Accelerator Award (AA/18/3/ 34220). MDT holds a Wellcome Trust Investigator Award (WT 202849/Z/ 16/Z) and an NIHR Senior Investigator Award. KK is supported by the National Institute for Health Research (NIHR) Applied Research Collaboration East Midlands (ARC EM). KK and MP are supported by the NIHR Leicester Biomedical Research Centre (BRC). MP is supported by a NIHR Development and Skills Enhancement Award. This work is carried out with the support of BREATHE-The Health Data Research Hub for Respiratory Health [MC_PC_19004] in partnership with SAIL Databank. BREATHE is funded through the UK Research and Innovation Industrial Strategy Challenge Fund and delivered through Health Data Research UK.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Study was approved by the Health Research Authority (Brighton and Sussex Research Ethics Committee; ethics reference: 20/HRA/4718). All participants gave electronic, informed consent. Trial ID: ISRCTN11811602.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesRequest data access and collaborations by following documentation found at https://www.uk-reach.org/main/data_sharing. https://www.uk-reach.org/main/data-sharing